- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
Patent holdings for IPC class C07D 401/04
Total number of patents in this class: 12020
10-year publication summary
|
732
|
783
|
790
|
774
|
763
|
743
|
722
|
774
|
709
|
444
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4880 |
273 |
| Novartis AG | 10744 |
206 |
| Celgene Corporation | 1400 |
165 |
| Merck Patent GmbH | 5815 |
155 |
| F. Hoffmann-La Roche AG | 7947 |
151 |
| Boehringer Ingelheim International GmbH | 4642 |
137 |
| Hoffmann-La Roche Inc. | 3439 |
116 |
| Vertex Pharmaceuticals Incorporated | 1600 |
114 |
| Janssen Pharmaceutica N.V. | 3394 |
111 |
| BASF SE | 20940 |
110 |
| Merck Sharp & Dohme LLC | 3751 |
108 |
| Takeda Pharmaceutical Company Limited | 2708 |
107 |
| Bayer AG | 3325 |
102 |
| AstraZeneca AB | 2892 |
96 |
| Pfizer Inc. | 3371 |
90 |
| Syngenta Crop Protection AG | 6074 |
90 |
| Gilead Sciences, Inc. | 2032 |
89 |
| FMC Corporation | 845 |
87 |
| Amgen Inc. | 4076 |
85 |
| Sumitomo Chemical Company, Limited | 9043 |
85 |
| Other owners | 9543 |